
GHK-Cu 100 mg — for laboratory research
€0.56 per mg
1 Products
Standard
€56,00
/each
3 Products
5% OFF
€53,20
/each
6 Products
10% OFF
€50,40
/each
8 Products
15% OFF
€47,60
/each
Independent lab report for this batch
- Independent lab
- Janoshik Analytical
- Batch number
- 2026-07-020
- Measured purity
- 99.609%
- Measured content
- 106.59 mg
- Analysed on
- 3 August 2026
Secure payment via
GHK-Cu 100 mg research-grade lyophilized copper peptide powder in a glass vial. Studied in preclinical models for skin regeneration, wound healing, collagen synthesis, and anti-inflammatory properties.
Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Technical Specifications
Frequently asked questions
GHK-Cu: compare vial sizes
| Product | Nominal content per vial | Price | Availability | Documentation |
|---|---|---|---|---|
| GHK-Cu 50 mg | 50 mg | €40.00 | In stock | Batch report on request |
| GHK-Cu 100 mg (this page) | 100 mg | €56.00 | In stock | Published report, batch 2026-07-020 |
FAQ on vial content and documentation
What is the difference between the vial sizes?
It is the same compound; only the nominal amount of lyophilisate per vial differs. The measured amount of a specific batch is stated in its report.
Where do I find the batch number?
The batch number is printed on the vial label. Compare it with the batch number in the report; the report only belongs to your vial when the numbers match.
Which report belongs to this size?
For GHK-Cu 100 mg a Janoshik Analytical report has been published for batch 2026-07-020 (analysed on 3 August 2026). It applies only to that batch and this vial size, not to other sizes.
Where do I find documentation and how do I verify it?
Published reports are listed on the lab results page. An original report can be checked with Janoshik Analytical's verification form using the task number and unique key from the report. The COA guide explains how to read a report.
Research context
GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine. In 1988 Maquart et al. described stimulation of collagen synthesis in fibroblast cultures (in vitro). This is cell-culture research: it is no promise of effects in humans and no evidence about our vials.
Source: Maquart FX et al. FEBS Lett. 1988. PMID 3169264 — PubMed · DOI
Intended exclusively for laboratory research and research purposes. Not for human or animal consumption.
Also known as
- GHK-Cu
- GHK cu
- ghkcu
- GHK-Cu peptide
- copper peptide
- koperpeptide
- GHK-Cu 50 mg
- GHK-Cu 100 mg
- tripeptide de cuivre
- koper tripeptide
Also searched as: GHK-Cu kopen.
All listed variants refer to the same research material, supplied strictly for laboratory research and research purposes only.
Frequently asked questions about these search terms
Research Overview
GHK-Cu is a naturally occurring copper tripeptide complex studied for its role in tissue remodeling, wound healing, and collagen synthesis. It is used in experimental models to explore mechanisms of skin regeneration and anti-inflammatory responses.
Primary Research Areas
- Skin regeneration & wound healing: models of dermal repair and tissue remodeling.
- Collagen synthesis: studies on extracellular matrix production and skin elasticity.
- Anti-inflammatory effects: research on inflammatory modulation in tissue repair contexts.
- Hair follicle research: experimental systems exploring hair growth and follicle health.
More research on GHK-Cu
Explore preclinical studies, mechanisms of action and references for GHK-Cu.
View researchFor Research Use Only
This product is intended solely for in-vitro research and laboratory use. Not intended for human consumption, diagnostic or therapeutic purposes.
Safety & Handling
Handle with appropriate protective equipment (gloves, lab coat, eye protection). Store according to product specifications. Consult the Safety Data Sheet (SDS) for full safety instructions.